Azelis Group NV: history, ownership, mission, how it works & makes money

From its 2001 origin as a merger of Novorchem and Arnaud to a public listing on Euronext Brussels in 2021, Azelis has grown into a specialty-chemicals and food-ingredients powerhouse operating in 65 countries with over 4,300 employees, serving more than 62,000 customers through 2,800+ principal relationships and a network of over 70 application laboratories; the company's commercial scale is reflected in a €4.2 billion turnover in 2024 and a resilient, cash-generative model evidenced by 11% free cash flow growth in H1 2025 and a liquidity buffer of €702 million in cash and unused facilities, while its ownership mix - including Invesco's reported 11.00% (26,838,187 shares) stake in Feb 2025 and BlackRock's adjusted 2.92% holding - plus inclusion in the BEL20 and BEL® ESG indices underscore market confidence as strategic acquisitions (notably the €300+ million backing from 3i in 2006) and the January 2025 'Impact 2030' sustainability program drive its mission to be the global innovation service provider that monetizes deep technical support, local-to-global distribution and value-added formulation services across life sciences and industrial chemicals

Azelis Group NV (AZE.BR): Intro

• 2001 - Founded through the merger of Novorchem (Italy) and Arnaud (France), entering the specialty chemicals and food ingredients distribution sector.
• 2004 - Expanded in Benelux via acquisition of Sibeco Group and Sepulchre, broadening market footprint and product range.
• 2005 - Acquired Brøste (Denmark), strengthening presence in the Nordic region.
• December 2006 - Global finance house 3i acquired Azelis from Cognetas (now Motion Equity Partners) for over €300 million, supporting accelerated expansion.
• 2021 - Listed on Euronext Brussels under ticker AZE (IPO signaling maturation and public-market access to capital).
• Late 2025 - Operates in 65 countries with over 4,300 employees, serves more than 62,000 customers and reported a turnover of €4.2 billion in 2024.

• Publicly traded company: shares listed on Euronext Brussels (AZE).
• Investor base includes institutional shareholders, previous private equity ownership (Cognetas/Motion Equity Partners) and 3i as a key historical investor.
• Decentralized operating model: regional business units and application laboratories combined with centralized strategy, M&A and finance functions.

• Mission focus: delivering specialty chemicals and food ingredients via technical application support, formulation expertise and value-added services across end-markets (coatings, adhesives, polymers, personal care, nutrition, etc.).
• Value proposition: combine local technical application knowledge with a broad global supplier and product portfolio to shorten development cycles for customers and suppliers.
• Further reading: Mission Statement, Vision, & Core Values (2026) of Azelis Group NV.

• Supplier partnerships: long-term distribution agreements with chemical and ingredient manufacturers (branded and specialty suppliers).
• Customer segments: formulators, manufacturers, and industrial end-users across multiple verticals (industrial chemicals, food & nutrition, personal care, agrochemicals, etc.).
• Technical services: application labs, formulation development, regulatory support, sample management and supply-chain logistics that increase customer switching costs.
• Geographic reach: local sales and technical teams in each operating country support global sourcing and regional market access.
• M&A-led growth: frequent acquisitions to expand product portfolios, regional footprints and technical capabilities.

• Product distribution margins - primary revenue: margin on sale of chemicals and ingredients purchased from suppliers and sold to customers.
• Value-added services - fees and embedded margin from formulation support, technical assistance and regulatory/compliance services.
• Logistics and supply-chain optimization - margin capture on warehousing, packaging, sampling and just-in-time delivery services.
• Pricing mix - combination of spot purchases, contract pricing and long-term framework agreements with both suppliers and customers.
• Scale benefits - purchasing power and centralized procurement enable improved gross margins and supplier terms as turnover grows.

Azelis Group NV (AZE.BR): History

• Founded: 2001
• IPO: 2021, Euronext Brussels (Ticker: AZE)
• Geographic footprint: Europe, APAC, Americas (operations in 50+ countries)
• Business model: specialty chemicals distribution, formulation and technical support services

• Public listing: Euronext Brussels (Ticker: AZE)
• Index membership: BEL20 and BEL® ESG
• Regulatory compliance: Belgian Transparency Law disclosures
• Investor trends: notable stake build-up by Invesco in Feb 2025; tactical reduction by BlackRock in Jan 2025

Azelis Group NV (AZE.BR): Ownership Structure

Azelis Group NV (AZE.BR) is a global specialty chemicals and food ingredients distributor and innovation service provider focused on delivering value through ideas, technical know‑how and formulation services. Below are the company's mission, core values and a snapshot of how it operates and generates revenue, with key metrics.

• Mission: To be the reference global innovation service provider in the specialty chemicals and food ingredients industry, delivering value through ideas and innovation.
• Sustainability focus: Launched the 'Impact 2030' program in January 2025 to accelerate environmental stewardship, social responsibility and ethical governance.
• Culture: Commitment to solid, honest and transparent relationships with employees, suppliers and customers; emphasis on care, inclusion and high ethical standards.
• Innovation & technical support: Maintains a network of over 70 application laboratories providing formulation development and technical guidance.
• Ethics & ratings: High industry sustainability rating (Sustainalytics top industry rating) reflecting governance and ESG leadership.

Ownership structure (illustrative breakdown of share distribution):

• Free float / institutional shareholders: ~68%
• Management & board members: ~10%
• Strategic / long‑term investors: ~20%
• Treasury shares / other: ~2%

How Azelis works and makes money:

• Distribution margin model: Buys raw materials and specialty ingredients from principal suppliers and resells to formulators, co‑packers and manufacturers; primary revenue from product margins and logistics services.
• Value‑added services: Charges for technical support, formulation development, regulatory guidance and co‑development - driven by the 70+ application labs and local technical staff.
• Sector diversification: Revenue split across Life Sciences, Industrial Chemicals and Food Ingredients, reducing volatility from any single end‑market.
• Scale & procurement: Global purchasing power and inventory management improve gross margins; cross‑selling and regional expansion raise customer lifetime value.
• Sustainability & innovation premium: Impact 2030 and ESG credentials enable access to sustainability‑focused customers and suppliers, supporting price premium and contract retention.

Key financial levers and performance drivers:

• Volume growth in emerging markets and specialty segments.
• Improved gross margin via supplier agreements and proprietary formulations.
• Operational leverage from centralized labs and shared services.
• Working capital optimization to reduce net debt and improve cash conversion.

Mission Statement, Vision, & Core Values (2026) of Azelis Group NV.

Azelis Group NV (AZE.BR): Mission and Values

• Global application laboratories: >70 labs providing hands‑on formulation development, technical guidance, and application testing close to customers.
• Customer and principal network: serves more than 62,000 customers and manages over 2,800 principal relationships to assemble complementary product portfolios.
• Market focus: dedicated industry, market and technical experts assigned to specific sectors within Life Sciences and Industrial Chemicals to ensure deep domain expertise.

• Local‑plus‑global model: combines a local footprint of labs and technical teams with international sourcing and market access to principals.
• Value creation for customers: technical support, formulation development, regulatory and market insight, and a digital service layer that streamlines ordering and product information.
• Value creation for principals: access to new markets through Azelis' distribution channels, formulation know‑how, and bundled complementary product offerings.

• Resilient, cash‑generative business model: reported 11% free cash flow growth in H1 2025, indicating efficient working‑capital and operational cash conversion.
• Strong liquidity: €702 million in combined cash and unused credit facilities as of H1 2025, supporting M&A, working capital and continuity of operations.

Azelis Group NV (AZE.BR): How It Works

• Primary revenue sources: distribution margins on specialty chemicals and food ingredients, technical and formulation services, logistics and value-added services.
• End markets served: personal care, pharmaceuticals, food & nutrition, coatings, adhesives, and industrial chemicals.
• Value drivers: application development, regulatory & compliance support, localized stocking & logistics, and digital customer platforms.

• Procurement & supplier relationships - negotiate distribution agreements and secure product allocations from principals.
• Value-added services - formulation support, regulatory guidance and technical lab services that command premium margins.
• Inventory & logistics optimization - centralized buying and local stocking lower working capital per sale while enabling faster delivery.
• Cross-selling & portfolio management - leverage customer relationships to sell broader sets of products across industries.
• Acquisitions & scale - targeted buys (including those in H1 2025) expand geographic footprint, add principals, and increase purchasing power.

• Scale: €4.2bn turnover provides bargaining power with suppliers and broad customer access.
• Cash generation: 11% FCF growth in H1 2025 underscores operational efficiency and ability to fund acquisitions and working capital.
• Growth levers: organic growth from innovation/sustainability-led product lines plus inorganic growth via acquisitions.
• Investor appeal: inclusion in BEL20 and BEL® ESG highlights both market prominence and ESG credentials, supporting access to capital and institutional investor interest.

Azelis Group NV (AZE.BR): How It Makes Money

• Global footprint: present in 65 countries with over 4,300 employees (2024).
• Customer and principal reach: serves more than 62,000 customers and manages over 2,800 principal relationships.
• Financial scale: turnover of €4.2 billion in 2024.

• Distribution margins: buys specialty chemicals and ingredients from principals and sells to formulators, contract manufacturers and end users. Margins derive from value-added logistics, regulatory and formulation support.
• Innovation services: technical application labs, formulation development, regulatory compliance and market insight services that command premium pricing and deepen customer ties.
• Blend of commoditized and specialty products: higher-margin specialty portfolios (food ingredients, personal care, coatings, adhesives) balance volume-driven commodity lines.
• Geographic diversification: sales across Europe, Asia-Pacific, the Americas and emerging markets reduce concentration risk and capture regional growth.
• M&A-led growth: acquired businesses extend product range, principal relationships and scale economies, increasing group EBITDA over time.
• Commercial model: long-term principal agreements and multi-year supply/consignment arrangements stabilize revenue streams and working capital turnover.

• Leadership: recognized as a top-tier specialty chemicals distributor with a broad principal network (2,800+), supporting resilience and cross-sell potential.
• Sustainability & ESG: inclusion in the BEL20 and BEL® ESG indices reflects corporate governance, sustainability initiatives and investor recognition in Belgium.
• Digital and innovation focus: investments in digital tools for sales, formulation and supply-chain transparency aim to increase service stickiness and margin expansion.
• Liquidity & balance sheet: a strong liquidity position and conservative working capital management support M&A capability and downturn resilience.
• Growth drivers: rising demand for high-performance ingredients in food, personal care and industrial applications, plus increased outsourcing of formulation expertise, underpin medium-term revenue growth.